TOKYO -- Japanese drugmaker Shionogi on Friday filed for emergency use approval for its COVID pill, paving the way for Japan's first domestically developed oral COVID treatment.
Osaka-based company is the first to develop treatment pill in Japan

Shionogi aims to make the drug available to the public this year. (Source photos by Jiji and courtesy of Shionogi)
TOKYO -- Japanese drugmaker Shionogi on Friday filed for emergency use approval for its COVID pill, paving the way for Japan's first domestically developed oral COVID treatment.